title: The rapid resolution of pseudohyperphosphatemia in an IGAκ multiple myeloma patient after therapy with a bortezomib-containing regimen: Report of the first case.
authors.forename: Muhammet
authors.initials: M
authors.lastname: Maden
authors.affiliation: Department of Hematology, Trakya University Medical Faculty, Edirne, Turkey.
authors.forename: Gulsum Emel
authors.initials: GE
authors.lastname: Pamuk
authors.forename: Veysi
authors.initials: V
authors.lastname: Asoglu
authors.forename: Omer Nuri
authors.initials: ON
authors.lastname: Pamuk
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069286:Bortezomib / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D054559:Hyperphosphatemia / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D007070:Immunoglobulin A / Q000276:immunology*; D007145:Immunoglobulin kappa-Chains / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D011379:Prognosis
chemical_list: D007070:Immunoglobulin A; D007145:Immunoglobulin kappa-Chains; D000069286:Bortezomib; D003907:Dexamethasone; D003520:Cyclophosphamide